Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1986 1
1991 1
1995 1
1997 1
1999 1
2002 1
2003 1
2004 1
2005 1
2006 2
2007 1
2008 2
2009 6
2010 4
2011 4
2012 4
2013 2
2014 2
2015 3
2016 3
2017 4
2018 6
2019 5
2020 1
2021 2
2022 5
2023 1
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

61 results

Results by year

Filters applied: . Clear all
Page 1
Cancer of unknown primary site.
Pavlidis N, Pentheroudakis G. Pavlidis N, et al. Lancet. 2012 Apr 14;379(9824):1428-35. doi: 10.1016/S0140-6736(11)61178-1. Epub 2012 Mar 12. Lancet. 2012. PMID: 22414598 Review.
Cancer of unknown primary site (CUP) is a well recognised clinical disorder, accounting for 3-5% of all malignant epithelial tumours. ...
Cancer of unknown primary site (CUP) is a well recognised clinical disorder, accounting for 3-5% of all m …
Cancer of unknown primary site.
Vajdic CM, Goldstein D. Vajdic CM, et al. Aust Fam Physician. 2015 Sep;44(9):640-3. Aust Fam Physician. 2015. PMID: 26488041 Free article. Review.
Site-specific therapy in cancers of unknown primary site: a systematic review and meta-analysis.
Ding Y, Jiang J, Xu J, Chen Y, Zheng Y, Jiang W, Mao C, Jiang H, Bao X, Shen Y, Li X, Teng L, Xu N. Ding Y, et al. ESMO Open. 2022 Apr;7(2):100407. doi: 10.1016/j.esmoop.2022.100407. Epub 2022 Mar 3. ESMO Open. 2022. PMID: 35248824 Free PMC article. Review.
BACKGROUND: Cancer of unknown primary site (CUP) is a term applied to characterize pathologically confirmed metastatic cancer with unknown primary tumor origin. ...
BACKGROUND: Cancer of unknown primary site (CUP) is a term applied to characterize pathologically confirm …
SEOM-GECOD clinical guideline for unknown primary cancer (2021).
Losa F, Fernández I, Etxaniz O, Giménez A, Gomila P, Iglesias L, Longo F, Nogales E, Sánchez A, Soler G. Losa F, et al. Clin Transl Oncol. 2022 Apr;24(4):681-692. doi: 10.1007/s12094-022-02806-x. Epub 2022 Mar 23. Clin Transl Oncol. 2022. PMID: 35320504 Free PMC article.
Cancer of unknown primary site (CUP) is defined as a heterogeneous group of tumors that appear as metastases, and of which standard diagnostic work-up fails to identify the origin. ...
Cancer of unknown primary site (CUP) is defined as a heterogeneous group of tumors that appear as metasta …
Cancer of unknown primary site: missing primary or missing biology?
Pentheroudakis G, Briasoulis E, Pavlidis N. Pentheroudakis G, et al. Oncologist. 2007 Apr;12(4):418-25. doi: 10.1634/theoncologist.12-4-418. Oncologist. 2007. PMID: 17470684 Free article. Review.
Cancer of unknown primary site (CUP) ranks as the fourth most common cause of cancer deaths and represents both a diagnostic and a management challenge. ...
Cancer of unknown primary site (CUP) ranks as the fourth most common cause of cancer deaths and represent …
Diagnostic and therapeutic management of cancer of an unknown primary.
Pavlidis N, Briasoulis E, Hainsworth J, Greco FA. Pavlidis N, et al. Eur J Cancer. 2003 Sep;39(14):1990-2005. doi: 10.1016/s0959-8049(03)00547-1. Eur J Cancer. 2003. PMID: 12957453 Review.
Metastatic Cancer of Unknown Primary Site (CUP) accounts for approximately 3% of all malignant neoplasms and is therefore one of the 10 most frequent cancer diagnoses in man. ...
Metastatic Cancer of Unknown Primary Site (CUP) accounts for approximately 3% of all malignant neoplasms …
Clinical and immune profiling for cancer of unknown primary site.
Haratani K, Hayashi H, Takahama T, Nakamura Y, Tomida S, Yoshida T, Chiba Y, Sawada T, Sakai K, Fujita Y, Togashi Y, Tanizaki J, Kawakami H, Ito A, Nishio K, Nakagawa K. Haratani K, et al. J Immunother Cancer. 2019 Sep 13;7(1):251. doi: 10.1186/s40425-019-0720-z. J Immunother Cancer. 2019. PMID: 31519206 Free PMC article.
BACKGROUND: Immune checkpoint inhibitors (ICIs) confer a survival benefit in many cancer types. Given that the survival outcome for cancer of unknown primary site (CUP) remains poor, we investigated the potential of CUP for immunotherapy. ...
BACKGROUND: Immune checkpoint inhibitors (ICIs) confer a survival benefit in many cancer types. Given that the survival outcome for cance …
Cancers of unknown primary site.
Aziz M, Afroz N, Awasthi A, Hasan SA, Ahmad I. Aziz M, et al. J Indian Med Assoc. 2011 Nov;109(11):812-4. J Indian Med Assoc. 2011. PMID: 22666938 Review.
The regression or dormancy of the primary tumour, the development of early, uncommon systemic metastases and the resistance to therapy are hallmark of this heterogeneous clinical entity. Still no consensus exists on whether cancer of unknown primary …
The regression or dormancy of the primary tumour, the development of early, uncommon systemic metastases and the resistance to therapy are h …
Cancer of unknown primary site.
Muir C. Muir C. Cancer. 1995 Jan 1;75(1 Suppl):353-6. doi: 10.1002/1097-0142(19950101)75:1+<353::aid-cncr2820751317>3.0.co;2-p. Cancer. 1995. PMID: 8001006
Cancer of unknown primary site: evolving understanding and management of patients.
Greco FA. Greco FA. Clin Adv Hematol Oncol. 2012 Aug;10(8):518-24. Clin Adv Hematol Oncol. 2012. PMID: 23073050 Review.
Cancer of unknown primary site is a common clinicopathologic syndrome representing a very heterogeneous group of patients with metastatic cancers and clinically undetectable primary tumor sites. ...
Cancer of unknown primary site is a common clinicopathologic syndrome representing a very heterogeneous g …
61 results